encompasses all ZYN nicotine pouches currently marketed by the company in the U.S. Swedish Match North America's president, Tom Hayes, commented on the FDA's decision, stating that it acknowledges ...

Nicotine pouches are rising in popularity — a trend that has raised concerns in the public health community. New research shows the use of nicotine pouches, like those sold by the brands Zyn ...

Nicotine pouches, like Zyn, are emerging as a potentially safer alternative to smoking, with FDA authorization based on reduced cancer risk compared to traditional smokeless tobacco. These pouches ...

It was the first time that regulators authorized the sale of nicotine pouches, according to CBS News. During the process to approve Zyn, the FDA looked at the risks and benefits of the products ...

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International's Zyn to help adult smokers cut back or quit cigarettes.

In January, the U.S. Food and Drug Administration (FDA) authorized Zyn to market flavored nicotine pouches to adults 21 and older, reasoning that they might offer a less harmful alternative to ...

The use of nicotine ... pouches between 2023 and 2024 among U.S. high school students. The FDA did not address this increase in lifetime use in its decision to authorize the marketing of Zyn ...

FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers The tobacco company posted several job listings at the end of March. The job listings include a logistics operation ...

The U.S. Food and Drug Administration (FDA) in January authorized Zyn to market flavored nicotine pouches to adults 21 and older, with the rationale that they might be a less harmful alternative ...

Why it matters: This is the first FDA authorization of any nicotine pouch, though that does not mean the product is "FDA approved." Driving the new: Zyn attracted online buzz with promotion from ...